Publicacións nas que colabora con MARTA EUGENIA ALARCON RIQUELME (15)

2024

  1. Response to the letter 'testing the effectiveness of MyPROSLE in classifying patients with lupus nephritis'

    Briefings in Bioinformatics

2023

  1. Differential diagnosis of systemic lupus erythematosus and Sjögren's syndrome using machine learning and multi-omics data

    Computers in Biology and Medicine, Vol. 152

2022

  1. Scoring personalized molecular portraits identify Systemic Lupus Erythematosus subtypes and predict individualized drug responses, symptomatology and disease progression

    Briefings in bioinformatics, Vol. 23, Núm. 5

2021

  1. A comprehensive database for integrated analysis of omics data in autoimmune diseases

    BMC Bioinformatics, Vol. 22, Núm. 1

  2. A survey of gene expression meta-analysis: Methods and applications

    Briefings in Bioinformatics, Vol. 22, Núm. 2, pp. 1694-1705

  3. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

  4. Transcription factor activity inference in systemic lupus erythematosus

    Life, Vol. 11, Núm. 4

2019

  1. Differential Treatments Based on Drug-induced Gene Expression Signatures and Longitudinal Systemic Lupus Erythematosus Stratification

    Scientific Reports, Vol. 9, Núm. 1

  2. Drug Repurposing From Transcriptome Data: Methods and Applications

    In Silico Drug Design: Repurposing Techniques and Methodologies (Elsevier), pp. 303-327

  3. ImaGEO: Integrative gene expression meta-analysis from GEO database

    Bioinformatics, Vol. 35, Núm. 5, pp. 880-882

2018

  1. Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression

    Arthritis and Rheumatology, Vol. 70, Núm. 12, pp. 2025-2035

2017

  1. MetaGenyo: A web tool for meta-analysis of genetic association studies

    BMC Bioinformatics, Vol. 18, Núm. 1

  2. Metagene projection characterizes GEN2.2 and CAL-1 as relevant human plasmacytoid dendritic cell models

    Bioinformatics, Vol. 33, Núm. 23, pp. 3691-3695

  3. Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis

    Arthritis Research and Therapy, Vol. 19, Núm. 1

2014

  1. Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome uncovered through gene expression meta-analysis

    Arthritis Research and Therapy, Vol. 16, Núm. 1